The table below shows CONMED Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q3 2025
Q2 2025
Q3 2024
Q2 2024
Q1 2024
Q3 2023
Revenue
$337.93M
$342.35M
$316.70M
$332.10M
$312.27M
$304.58M
Cost of revenue
$171.81M
$154.03M
$137.71M
$148.37M
$140.31M
$136.52M
Gross profit
$166.12M
$188.32M
$179.00M
$183.73M
$171.97M
$168.06M
R&D
$13.90M
$14.14M
$13.56M
$14.10M
$13.59M
$12.46M
CNMD annual revenue (10-K history)
CONMED Corp reported annual revenue of $1.37B for fiscal year 2025. That is up 5.2% from $1.31B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $763.52M (FY 2016) to $1.37B. Figures come from the company's audited annual reports as filed with the SEC.
